Board of Directors Finance Presentation 2015/16. Friday 25th September 2015

Similar documents
Report. Chris Ford Joint Chief Finance Officer


SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000

NHS Great Yarmouth and Waveney CCG

Integrated Performance Report M Executive Summary

Board of Directors Meeting Report 25 May Agenda item 49/16

Item 8iii. Draft financial Plan Document for Moorfields Eye Hospital NHS Foundation trust. Prepared by:

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015]

Board Sponsor: Sarah Truelove, Director of Finance and Deputy Chief Executive. Author: Lynne Abbott, Head of Financial Management

NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY 24 April 2018

Kingston Hospital NHS Foundation Trust. Finance Report December 2017 (Month 09)

Corporate Performance Report 2015/16

NHS financial sustainability

Medium Term Financial Strategy

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07)

Refreshing TCP Financial Plans for 2018/19

UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Finance Report. Paul Goddard, Assistant Director of Finance

2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval

Financial Framework for Integrated Care Systems 2018/19

SOUTHPORT & ORMSKIRK HOSPITAL NHS Trust

BOARD PAPER - NHS ENGLAND

Annual Audit Letter. Hereford Hospitals NHS Trust Audit 2010/11

NHS ENGLAND BOARD PAPER

Annual Audit Letter Southport and Ormskirk Hospital NHS Trust 13 July 2016

Finance and QIPP (Quality, Innovation, Productivity & Prevention) Plan 2015/16 John Ingham, Chief Financial Officer

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan.

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014

BOARD PAPER - NHS ENGLAND

Report to: Public Trust Board Agenda item: 2.2 Date of Meeting: 12 May 2010

Jason Dorsett, Chief Finance Officer

Title: NHS Funding Settlement Impact and Budget Setting 2018/19

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST. Corporate Monitoring Report. Alastair Matthews, Director of Finance

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015

SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST

PAPER FOR THE LUTON CLINICAL COMMMISSIONING GROUP PUBLIC BOARD TO BE HELD ON TUESDAY 24 th JUNE Nigel Armitt, Chief Finance Officer

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015

Finance Report M4 2016/17

George Eliot Hospital NHS Trust - Securing a sustainable future Project. Annex A

CoG (07/16) Item 6.2. Council of Governors. Dr Jim Whittingham. Dr Jim Whittingham. Board Highlights Report N/A

Month 10 Finance Report

Nicci Briggs Director of Finance. Nicci Briggs Director of Finance PFR

2017/18 Quality, Innovation, Productivity and Prevention Programme

2015/16 Savings Plan 2 April 2015

COST IMPROVEMENT PROGRAMME 2011/12 MONTH 6 REPORT

The Annual Audit Letter for Chorley and South Ribble Clinical Commissioning Group

Finance Report: 2014/15 Month 9. Maria Moore Deputy Chief Executive/Director of Finance TRUST BOARD 29 th January 2015

The Annual Audit Letter for Staffordshire and Stoke on Trent Partnership NHS Trust

NHS financial temperature check

Item 6. Monthly Finance Report For November Prepared by: Stephen Dunham Financial Controller

Commissioning for Quality and Innovation (CQUIN)

Annual Audit Letter Year ending 31 March NHS Shropshire CCG 27 June 2018

NHSGGC Revenue and Capital Report to 31 August 2018 (Paper 18/54) Board Official

The Royal Wolverhampton NHS Trust

2018/19 Technical Guidance Annex D NHS England Guidance for Finance Business Rules

Chief Finance Officer. The CCG reports a surplus of 79k for the year after holding a projected a surplus of 32k for the last three months.

Finance and Performance Committee

Trust Board Meeting: Wednesday 13 November 2013 TB

Financial health of the higher education sector

3 February 2016 Enclosure H1

Approve X Ratify For Discuss For Information X

2018 Half Year Results Presentation. 18 September 2018

Catherine Phillips, Director of Finance Sarah Elsey, Interim Head of Financial Management

NHS Improvement (Monitor and the NHS Trust Development Authority)

Report to the Sutton Clinical Commissioning Group Board

Board Meeting BOARD OFFICIAL

REPORT TO BOARD. 10 th June Agenda No St George s University Hospital Foundation Trust Review

Supporting all NHS Trusts to achieve NHS Foundation Trust status by April 2014

Budget and Capital Plan 2018/19. This paper provides the Board with a summary of the indicative budget and capital plan approved by FIC for noting.

The Royal Wolverhampton NHS Trust

NHS Isle of Wight CCG

Economic impact of NHS spending in the Black Country. 21 July 2017

EXECUTIVE SUMMARY. REPORT TO: Trust Board DATE: Thursday 3 January 2019 AGENDA NO: 3.1 AGENDA ITEM: Financial Report November 2018 SPONSOR:

Scottish Government Draft 2010/11 Budget Proposals. Response to the call for evidence from the Health and Sport Committee

Corporate Performance Report 2013/14

Budget Setting Methodology 2017/18

Agenda Item: 4.4 Finance Report

The Annual Audit Letter for West Hertfordshire Hospitals NHS Trust

External Audit: Progress Report and Technical. Update. Page 73. Lincolnshire County Council. Audit Committee March 2017

BOARD MEETING DATE OF MEETING: 18 JULY Month 3 (June) Financial Performance Update Eifion Williams, Director of Finance

(Appendix 6 provides a summary of the IJB s reserves at 30 th November 2017)

Consideration of Going concern Status 2014/15 Accounts

NHS North Somerset Clinical Commissioning Group Risk Management Strategy and Framework

NHS financial temperature check

Finance Assurance Report. February 2017

Finance & Performance Committee

Overview of the 2015 Spending Review

Clive Field, Interim Director of Finance and Performance. 20 June 2016

2017/18 Quality, Innovation, Productivity and Prevention Programme

Appendix:6.2 MEETING: Paul Sinden Director of Commissioning CONTACT AUTHOR: DETAILS: SUMMARY:

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 4 July 2018

2018/19 Planning, Commissioning Intentions and Governing Body Assurance Framework

Supporting NHS providers: guidance on merger benefits

OFFICIAL. Date and Time 15 th May 2018 SPA Boardroom, Pacific Quay Forensic Services Budget Management and Month End Guidelines Item Number 10.

The Committee is asked to receive this report and note the recommended actions.

TAMESIDE AND GLOSSOP SINGLE COMMISSIONING BOARD. 11 April 2017

Bracknell Forest Council

Finance Assurance Report. March 2017

healthcare; 6. To play an active and influential role in shaping SE London and London wide X commissioning.

Financial Report at Month 6

Transcription:

Board of Directors Finance Presentation 2015/16 Friday 25th September 2015

1. Summary of 2015/16 financial position This presentation is to update the Board in public of our latest financial position. Deficit - (5.0)m Arising from: New investments in quality (mainly increased staff levels)- 1.9m; New cost pressures (Clinical negligence cover and pay inflation & increments) - 3.9m; and Our plan includes a Transformation target of 7.6m Risk remains on; CCG contract ( 4.2m in dispute) which could add to the deficit; Additional costs to deliver our winter plan (unfunded) 2.2m; and Transformation delivery - 1.7m mainly arising from bed based schemes due to external factors within the system. Depending on the risks above, the deficit could grow to an anticipated (9.0)m by the end of the financial year.

1. Introduction & Context At the Trust s Board of Directors meeting held in March it was acknowledged that the Trust s finances look very difficult with a worst case scenario (17.0)m deficit position for 2015/16. The Trust s 2015/16 Financial Plan has not been made publicly available because of the extended contract negotiations with GY&W CCG this year. The Board of Directors have considered very carefully the implications of not making publicly available our financial plan as we want to be open and transparent in all that we do. The Trust s approach to non-disclosure was discussed and acknowledged by FT sector regulator, Monitor. As the contract negotiations with GY&W CCG has entered its final stage the Trust is now in a position to share its financial information publicly again.

2. 2015/16 Contract negotiations The Trust entered usual contract negotiations with GY&W CCG in January 2015. The contract for 2015/16 is the second and final year of a two year NHS healthcare contract that commenced on 1 April 2014. After several weeks of negotiations, the Trust and the CCG could not reach agreement in the usual way on the overall activity and funding levels. The value of the dispute with the CCG is 4.2m. The CCG therefore enacted the dispute resolution process in April 2015. Further escalation and meetings were held between other Executives and ultimately escalated to the CEOs. Despite best efforts of officers of the Trust, this did not resolve the dispute. The CCG has therefore compelled the Trust to enter a mediation process in May 2015 with an independent mediator jointly appointed by the CCG and the Trust in June 2015.

2. 2015/16 Contract negotiations An external mediation day facilitated by an independent mediator took place in July 2015. Despite best efforts of Executives of the Trust this did not resolve the dispute. Several offers and counter-offers subsequently passed between the Trust and the CCG and whilst this resulted in many of the issues being resolved, this did not resolve all the matters in dispute. The CCG therefore compelled the Trust to follow a legal process known as Expert Determination in early September 2015 and a legal expert will now determine the outcome of the remaining disputed issues with the contract. The main healthcare contract negotiations with GY&W CCG has therefore entered its final stage and a decision will be taken based on the merits of each parties case.

2. 2015/16 Contract negotiations The following chart shows the changes in expected income for agreed contracts and commissioner proposed figure from GY&W. Actual Expected Variance 2014/15 2015/16 Commissioner 'm 'm 'm Great Yarmouth and Waveney 127.9 119.6-8.3 North Norfolk CCG 3.8 3.6-0.2 South Norfolk CCG 0.8 0.6-0.2 Norwich CCG 0.6 1.1 0.4 NHS England - Specialised 8.0 7.3-0.7 NHS England - Non Specialised 2.5 2.0-0.5 Total Income from Contracts 143.6 134.1-9.5 This is set against a backdrop of increasing patient activity in Emergency Medical admissions up 1.82% Year on year YTD (up 2.1% in Q2 so far). Activity is significantly at risk of over-performance on the above expected levels based on current Month 5 data. This has been highlighted to relevant commissioners.

3. 2015/16 Financial Plan headlines 3.1 Income Statement The 2015/16 Financial Plan and Budgets were assembled based on a realistic assessment of the most likely achievable financial position for the Trust. The first draft of the Trust s financial plan for 2015/16, submitted to FT regulator, Monitor on 7 th April 2015, reflected an (8.1)m deficit position. Following robust challenge from the Board of Directors further action was taken to improve the position which resulted in a final version of the financial plan reflecting a (5.0)m deficit. This was submitted to Monitor on 14 th May 2015. The safety of patients is our priority as set out in our Trust values and the Board of Directors have made decisions to invest and maintain staffing levels to meet current demand which in turn has had an impact on the Trust s financial position.

3. 2015/16 Financial Plan headlines 3.2 Transformation and Cost Improvement Programme The Transformation Board has developed plans for 2015-16 that build on the previous two year transformation and recognises the need to support the longer term financial outlook. The programme will support service improvement, integrated projects that will benefits the wider health system and new ways of working. The financial plan includes a Transformation target of 7.6m this financial year. This represents 4.2% of total costs which is considered to be the maximum level considered to be safely achievable. A Clinical Quality Risk Assessment process is in place to ensure transformation savings do not adverse impact on quality of care to patients. Transformation delivery risk remains is in relation to bed based schemes where the Trust is not in a position to close beds in line with plan due to current level of demand and external factors within the system.

3. 2015/16 Financial Plan headlines 3.3 Capital Expenditure In total the Capital Programme (NHS and Donated) has currently earmarked 15.9m to be spent during 2015/16. Strategic Capital Development incorporating the final phases of the Theatres upgrade; Ongoing maintenance of the Estate and Facilities; Upgrades to Residences; Carbon Reduction Initiatives; Information Technology; and Ongoing Divisional Equipment including replacement of the Trust s two CT Scanners and the MRI Scanner. The capital programme is funded from the Trust s cumulative historic surpluses since becoming an FT.

3. 2015/16 Financial Plan headlines 3.4 Monitor Regulatory Risk Ratings With effect from 1 st August 2015 a revised Risk Assessment Framework has been issued, which includes the replacement of the Continuity of Services Risk Rating (CoSRR) with the Financial Sustainability Risk Rating (FSRR). The new FSRR ratings move the Trust into a regime more focussed on Income Statement performance. The table below provides a summary of the 15/16 CoSRR and FSRR performance. 15/16 Plan Q1 Actual M5 Actual CoSRR 3 3 3 FSRR 2 2 2 Monitors risk ratings (both CoSRR and FSRR) range from 1 to 4 with 1 being highest financial risk, 4 being lowest financial risk.

4. Month 5 Actual Financial Position of the Trust The Month 5 2015/16 Financial position of the Trust is summarised as follows; Income Overall income is ahead of plan at Month 5 with some overperformance against budgeted income targets, with a net favourable operating income variance of 822k. Expenditure Overall 889k above plan Overspend on pay is driven by medical staffing particularly in covering vacancies to maintain current service levels. There has been on-going Healthcare Assistant bank and overtime costs within ward areas to maintain the current bed base and enhanced supervision for patients requiring one to one care. New FSRR measure - 2, in line with plan. Based on the Month 5 position, the Trust is currently on track to deliver its (5.0)m planned deficit for 2015/16. However, there are remaining risks and uncertainties, in particular the contract position with the CCG and the delivery of the Transformation Programme.

5. Steps already taken to reduce risks and uncertainties and to minimise the deficit Director of Finance tasked Divisional Management Teams to review all areas of spend as part of a Financial Recovery Plan; Executive Team review of Transformation plans and potential mitigation actions to improve the in-year position; Review of agency spend commissioned from Internal Audit; Strengthened Transformation Resources and commissioned an Internal Audit review; Commenced work on Norfolk hospitals joint Transformation; Signed a Nursing Agency Master vendor Interim Contract; Continued with e-roster project to improve rota management; and Continued with additional overseas nurse recruitment.

6. Next steps Whilst the Trust is currently in line with its planned deficit at Month 5, there are a series of further actions we are taking to improve on the position, as follows; Develop strategic plans to return to financial sustainability; Sign off and present to Board of Directors the Financial Recovery Plan; Implement Service Line Reporting to improve understanding of service income and costs in greater detail; Focus medical agency steering group to review controls and engage medical leadership to reduce reliance on agency spend; and Accelerate partnership working with other providers in line with agreed principles to reduce costs, work more collaboratively and improve clinical networking.

Any questions?